Bcl-2 expression regulates sodium butyrate-induced apoptosis in human MCF-7 breast cancer cells

Cell Growth and Differentiation

Volumn 7, Issue 3, 1996, Pages 311-318

  Mandal, Mahitosh ^a   Kumar, Rakesh ^a,b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL GROWTH; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TUMOR GROWTH;

APOPTOSIS; BREAST NEOPLASMS; BUTYRIC ACID; BUTYRIC ACIDS; CARCINOMA; CELL DIVISION; DOWN-REGULATION; HUMANS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; TUMOR CELLS, CULTURED;

MAMMALIA; MINK CELL FOCUS-FORMING VIRUS;

EID: 0029805777     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Steller, H. Mechanisms and genes of cellular suicide. Science (Washington DC), 267: 1445-1448, 1995.
2. Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease. Science (Washington DC), 267: 1456-1462, 1995.
3. Williams, G. T., and Smith, C. A. Molecular regulation of apoptosis: genetic controls on cell death. Cell, 74: 777-779, 1993.
4. Korsmeyer, S. J. Bcl-2 initiates a new category of oncogenes: regulator of cell death. Blood, 80: 879-886, 1992.
5. Hockenbery, D. M., Zutter, M., Hickey, W., Nahm, M., and Korsmeyer, S J Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. USA, 88: 6961-6965, 1991.
6. Boise, L. H , Gonzalez-Garcia, M., Postema, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nunez, G., and Thompson, C. B. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell, 74: 597-608, 1993.
7. Gottschalk, A. R., Boise, L. H., Thompson, C. B., and Quintans, J. Identification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by bcl-X but not bcl-2. Proc. Natl Acad. Sci USA, 91. 7350-7354, 1994.
8. Oltvai, Z., Milliman, C. L., and Korsmeyer, S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74: 609-619, 1993.
9. Tsujimoto, Y., Gorham, J., Cossman, J., Jaffe, E., and Croce, C. M. The t(14,18) chromosome translocation involved in B-cell neoplasms results from mistake in VDJ joining. Science (Washington DC), 299: 1390-1393, 1985.
10. Hockenbery, D. M., Nunez, G., Milliman, C., Schreiber, R. D., and Korsmeyer, S. J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (Lond.), 348: 334-336, 1990.
11. Sentman, C. L., Shutter, J. R., Hockenbery, D., Kanagawa, O. and Korsmeyer, S. J. Bcl- 2 inhibits multiple forms of apoptosis but not negative selective in thymocytes. Cell, 67: 879-898, 1991.
12. Hickman, J. A. Apoptosis induced by anticancer drugs. Cancer Metastasis Rev., 11. 121-139, 1992.
13. Seto, M., Jaeger, U., Hockett, R. D., Graminger, W., Bennett S., Goldman, P., and Korsmeyer, S. J. Alternative promoters and exons, somatic mutation and downregulation of the Bcl-2-1g fusion gene in lymphoma. EMBO J., 7: 123-131, 1988
14. Fisher, T. C., Milner, A. E., Gregory, C. D., Jackman, A. L, and Aherne, G. W. Bcl-2 modulation of apoptosis induced by anticancer drug: resistance pathways thymidylate stress is independent of classical resistance pathways. Cancer Res., 53: 3321-3326, 1993.
15. Carson, W. E., Haldar, S., Baiocchi, R. A., Croce, C. M., and Caligiuri, M. A. The c-kit ligand suppresses apoptosis of natural killer cells through the upregulation of bcl-2. Proc. Natl. Acad. Sci. USA, 91: 7553-7557, 1994.
16. Berchem, G. J., Bosseler, M. M., Sugars, L. Y., Voeller, H. J., Zeitlin, S., and Gelmann, E. P. Andragens induce resistance to bcl-2-mediated apoptosis in LNCaP prostate cancer cells. Cancer Res., 55: 735-738, 1995.
17. Lotem, J., and Sachs, L. Control of sensitivity to induction of apoptosis in myeloid leukemia cells by differentiation and bcl-2 dependent and independent pathways. Cell Growth & Differ., 5: 321-327, 1994.
18. L and bax in the control of apoptosis by hematopoietic cytokines and dexamethasone. Cell Growth & Differ., 6: 647-653, 1995.
19. Carson, D. A , and Ribeiro, J. M. Apoptosis and disease. Lancet, 341: 1251-1254, 1993.
20. Doll, R., and Peto. R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States. Oxford: Oxford University Press, 1991.
21. Snyderwine, E. Some perspectives on the nutritional aspects of breast cancer research. Cancer (Phila.), 74: 1070-1077, 1994.
22. Cummings, J. H. Short-chain fatty acids in the human colon. Gut, 22: 763-779, 1981.
23. Kruh, J. Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol Cell. Biochem., 42: 65-82, 1982.
24. Planchon, P., Raux, H., Magnien, V., Ronco, G., Villa, P., Crepin, M., and Brouty-Boye, D. New stable butyrate derivatives alter proliferation and differentiation in human mammary cells. Int. J. Cancer, 48: 443-449, 1991.
25. Planchon, P., Magnien, V., Starzec, A., and Prevost, G. Selection of a highly tumorigenic breast cancer cell line sensitive to estradiol to evidence in vivo tumor-inhibitory effect of butyrate derived monobut-3. Life Sci., 55: 951-959, 1994.
26. Abe, M., and Kufe, D. Sodium butyrate induction of milk-related antigens in human MCF-7 breast carcinoma cells. Cancer Res., 44: 4574-4577, 1984.
27. Abe, M., and Kufe, D. Effect of maturational agents on expression and secretion of two partially characterized high molecular weight milk-related glycoproteins in MCF-7 breast carcinoma cells. J. Cell Physiol., 126: 126-132, 1986.
28. Hague, A., Manning, A. M., Hanlon, K A., Huschtscha, L. I., Hart, D., and Paraskeva, C. P. Sodium butyrate induces apoptosis in human colonic tumor cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int. J. Cancer, 55: 498-505, 1993.
29. Hague, A., Elder, D. J. E , Hicks, D. J., and Paraskeva, C. Apoptosis in colorectal tumors cells: induction by the short chain fatty acids butyrate, propionate, and acetate and by the bile salt deoxycholate. Int. J. Cancer, 60: 400-406, 1995.
30. Filippovich, I., Sorokina, N., Khanna, K. K., and Lavin, M. F. Butyrate induced apoptosis in lymphoid cells preceded by transient overexpression of HSP70 mRNA. Biochem. Biophysical. Res. Commun., 198: 257-265, 1994.
31. Leist, M., Gartner, F., Bohlinger, I., Tiegs, G., and Wendel, A. Application of the cell death ELISA for the detection of tumor necrosis factor induced DNA fragmentation in munne models of inflammatory organ failure. Biochemica, 11: 20-22, 1994.
32. Sumantran, V. N., Ealovega, M. W., Nunez, G., Clarke, M. F., and Wicha, M. S. Overexpression of Bcl-Xs sensitizes MCF-7 cells to chemotherapy-induced apoptosis. Cancer Res., 55: 2507-2510, 1995.
33. Wang, T. Y., and Phang, J. M. Effect of estrogen on apoptotic pathways in human breast cancer cell MCF-7. Cancer Res., 55. 2487-2489, 1995.
34. Oberhammer, F, Wilson, J., Dive, C., Morris, I. D., Hickman, J. A., Wakeling, A. E., Walker, P. R., and Sikorska, M. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J., 12: 3679-3684, 1993
35. Fornari, F. A., Jr. Jarvis, W. D., Grant, S., Orr, M. S., Randolph, J. K., White, F. K., Munaw, V. R., Lovings, E. T., Freeman, R. H., and Gerwitz, D. A. Induction of differentiation and growth arrest is associated with nascent DNA fragmentation and reduced c-myc expression in MCF-7 human breast cancer cells after continuous exposure to sublethal concentrations of doxorubicin. Cell Growth & Differ., 5: 723-733, 1994.
36. Hattori, H., Liu, Y-C., Tohnai, I., Ueda, M., Kaneda, T., Kobayashi, T., Tanabe, K., and Ohtsuka, K. Intracellular localization and partial amino acid sequence of a stress-inducible 40 kDa protein in Hela cells. Cell Struct. & Funct., 17: 77-86, 1992.
37. Dole, M , Nunez, G , Merchant, A. K., Maybaum, J., Rode, C. K., Bloch, C. A., and Castle, V. P. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res , 54: 3253-3259, 1994.
38. McDonell, T. J., Deane, N., Platt, F. M., Nunez, G., McKearn, J. P., and Korsmeyer, S. J. Bcl-2 immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell, 57: 79-88, 1989.
39. Benz, C. C., Scott, G. K., Sarup, J. C., Johnson, R. M., Tripathy, D., Coronado, E., Shepard, M., and Osborne, C. K. Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu. Breast Cancer Res. Treat., 24: 85-95, 1995.
40. Edmondson, J. M., Armstrong, L. S., and Martinez, A. O. A rapid and simple MTT-based spectrophotometric assay for determining drug sensitivity in monolayer cultures. J. Tissue Culture Methods, 11: 5-17, 1988.
41. Kumar, R., and Mendelsohn, J. Growth regulation of A431 cells, modulation of expression of transforming growth factor-mRNA and 2′,5′-oligoadenylate synthetase activity. J. Biol. Chem., 265: 4578-4582, 1990.
42. Del-Biobo, G., Skierski, J. C., and Darzynkiewicz, Z. The concentration dependent diversity of effects of DNA topoisomerase I and II inhibitors on the cell cycle of HL-60 cells. Exp. Cell Res., 195: 485-491, 1991.
43. Kumar, R., and Atlas, I. Interferon-α induces the expression of retinoblastoma gene product in human Burkitt's lymphoma Daudi cells: role in growth regulation. Proc. Natl. Acad. Sci. USA, 89: 6599-6603, 1992.
44. Kumar, R., Korutla, L., Zhang, K. Cell cycle-dependent modulation of α interferon inducible genes expression and activation of signaling components in Daudi cells. J. Biol. Chem., 269: 25437-25441, 1994.
45. Tsujimoto, Y., and Croce, C. A. Analysis of the structure, transcripts, and protein products of bcl-2: the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. USA, 83: 5214-5218, 1986
46. Kumar, R., Tiwari, R., Kusari, J., and Sen, G. Clonal derivatives of RD-114 cells respond differently in their antiviral and gene inducing responses to interferons. J. Virol., 61: 2727-2732, 1987.